Cargando…
Elucidation of Cellular Responses in Non-human Primates With Chronic Schistosomiasis Followed by Praziquantel Treatment
For decades, mass drug treatment with praziquantel (PZQ) has been utilized to treat schistosomiasis, yet reinfection and the risk of drug resistance are among the various factors precluding successful elimination of schistosomiasis. Tractable models that replicate “real world” field conditions are c...
Autores principales: | Melkus, Michael W., Le, Loc, Siddiqui, Arif J., Molehin, Adebayo J., Zhang, Weidong, Lazarus, Samra, Siddiqui, Afzal A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050631/ https://www.ncbi.nlm.nih.gov/pubmed/32154190 http://dx.doi.org/10.3389/fcimb.2020.00057 |
Ejemplares similares
-
Schistosoma mansoni antigen Sm-p80: prophylactic efficacy using TLR4 agonist vaccine adjuvant glucopyranosyl lipid A-Alum in murine and non-human primate models
por: Zhang, Weidong, et al.
Publicado: (2018) -
Sm-p80-based schistosomiasis vaccine mediated epistatic interactions identified potential immune signatures for vaccine efficacy in mice and baboons
por: Rojo, Juan U., et al.
Publicado: (2017) -
Chronic whipworm infection exacerbates Schistosoma mansoni egg-induced hepatopathology in non-human primates
por: Le, Loc, et al.
Publicado: (2020) -
Schistosomiasis vaccine development: update on human clinical trials
por: Molehin, Adebayo J.
Publicado: (2020) -
Elucidating the role played by bone marrow in visceral leishmaniasis
por: Veras, Patricia Sampaio Tavares, et al.
Publicado: (2023)